Cancer Pain—From Novel Mechanisms to Clinical Management
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 May 2025 | Viewed by 80
Special Issue Editors
Interests: molecules and ion channels; neural circuits; algesia and analgesia; consciousness and anesthesia
Special Issue Information
Dear Colleagues,
Cancer pain is a significant clinical challenge that greatly diminishes the quality of life for patients with advanced malignancies and complicates disease management. Conventional analgesics, such as NSAIDs and opioids, often provide inadequate relief and cause side effects, highlighting the need for new, mechanism-based therapies.
This Special Issue, "Cancer Pain—From Novel Mechanisms to Clinical Management", seeks articles exploring innovative approaches to cancer pain management, from basic science to clinical applications. We welcome original research, reviews, and case studies in the following areas:
- Clinical Research: Emerging pharmaceutical interventions.
- Basic Science: New mechanisms and therapeutic targets in cancer pain.
- Reviews: Overviews of current and emerging therapies.
We aim to gather the latest research to improve the understanding and treatment of cancer pain. We look forward to your contributions.
Prof. Dr. Xuejun Song
Dr. Xiaodong Liu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer pain
- novel analgesics
- mechanism-driven therapeies
- pain management
- palliative care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
